Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BIOA-B.ST Stock Summary
Top 10 Correlated ETFs
BIOA-B.ST
In the News
BIOA-B.ST Financial details
Company Rating
Sell
Market Cap
17.48B
Income
229.25M
Revenue
615.99M
Book val./share
11.85
Cash/share
6.93
Dividend
-
Dividend %
-
Employees
88
Optionable
No
Shortable
Yes
Earnings
17 May 2024
P/E
93.86
Forward P/E
-
PEG
-0.45
P/S
39.2
P/B
21.5
P/C
28.43
P/FCF
191.82
Quick Ratio
6.21
Current Ratio
10.81
Debt / Equity
0
LT Debt / Equity
-
-
-
EPS (TTM)
2.6
EPS next Y
-
EPS next Q
-
EPS this Y
-2100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
21.06%
Revenue last 5Y
16.93%
Revenue Q/Q
-94.72%
EPS Q/Q
-169.72%
-
-
-
-
SMA20
-10.92%
SMA50
-8.11%
SMA100
-10.92%
Inst Own
-
Inst Trans
-
ROA
21%
ROE
26%
ROC
0.24%
Gross Margin
88%
Oper. Margin
44%
Profit Margin
43%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
191.5-392.0
52W High
-49.74%
52W Low
+3.14%
RSI
42
Rel Volume
1.09
Avg Volume
134.63K
Volume
146.9K
Perf Week
-5.29%
Perf Month
-7.51%
Perf Quarter
-17.44%
Perf Half Y
-21.95%
-
-
-
-
Beta
-0.17
-
-
Volatility
5.25%, 11.99%
Prev Close
-3.34%
Price
197
Change
-1.6%
BIOA-B.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.2 | 0.71 | 0.26 | 2.59 | 6.99 | |
Net income per share | 1 | -0.78 | -1.36 | -0.13 | 2.6 | |
Operating cash flow per share | 3.72 | -1.05 | -1.6 | -0.36 | 3.39 | |
Free cash flow per share | 3.68 | -1.19 | -1.64 | -0.5 | 3.39 | |
Cash per share | 12.64 | 11.36 | 9.63 | 9.14 | 6.94 | |
Book value per share | 11.07 | 10.3 | 8.96 | 8.93 | 11.87 | |
Tangible book value per share | 11.07 | 10.3 | 8.96 | 8.93 | 11.87 | |
Share holders equity per share | 11.07 | 10.3 | 8.96 | 8.93 | 11.87 | |
Interest debt per share | 0.32 | 0.25 | 0.19 | 0.12 | 0.15 | |
Market cap | 8.36B | 8.4B | 10.5B | 23.96B | 23.61B | |
Enterprise value | 7.27B | 7.42B | 9.66B | 23.16B | 23.01B | |
P/E ratio | 94.46 | -122.61 | -87.63 | -2.14K | 103 | |
Price to sales ratio | 29.66 | 134.74 | 453.5 | 104.94 | 38.33 | |
POCF ratio | 25.54 | -90.98 | -74.73 | -757.2 | 78.96 | |
PFCF ratio | 25.8 | -80.15 | -72.47 | -539.75 | 78.96 | |
P/B Ratio | 8.58 | 9.26 | 13.31 | 30.47 | 22.56 | |
PTB ratio | 8.58 | 9.26 | 13.31 | 30.47 | 22.56 | |
EV to sales | 25.81 | 119.04 | 417.53 | 101.45 | 37.35 | |
Enterprise value over EBITDA | 58.94 | -99.79 | -76.36 | 5.75K | 83.62 | |
EV to operating cash flow | 22.23 | -80.37 | -68.81 | -732.06 | 76.94 | |
EV to free cash flow | 22.45 | -70.81 | -66.72 | -521.83 | 76.94 | |
Earnings yield | 0.01 | -0.01 | -0.01 | 0 | 0.01 | |
Free cash flow yield | 0.04 | -0.01 | -0.01 | 0 | 0.01 | |
Debt to equity | 0.03 | 0.02 | 0.02 | 0.01 | 0 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.01 | 0 | |
Net debt to EBITDA | -8.8 | 13.17 | 6.58 | -197.6 | -2.2 | |
Current ratio | 7.67 | 9.27 | 8.51 | 11.58 | 9.22 | |
Interest coverage | 94.41 | -74.97 | -166.73 | -18.17 | 24.72 | |
Income quality | 2.91 | 1.09 | 1.01 | 1.81 | 1.3 | |
Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
Payout ratio | 1.49 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.37 | 1.07 | 0 | 0 | |
Research and developement to revenue | 0.26 | 0.81 | 2.38 | 0.33 | 0.15 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.01 | 0.14 | 0.03 | 0.4 | 0 | |
Capex to revenue | -0.01 | -0.2 | -0.19 | -0.06 | 0 | |
Capex to depreciation | -0.35 | -1.14 | -0.34 | -0.9 | 0 | |
Stock based compensation to revenue | 0 | 0.02 | 0.07 | 0.01 | 0 | |
Graham number | 15.82 | 13.43 | 16.56 | 5.05 | 26.35 | |
ROIC | 0.09 | -0.07 | -0.15 | -0.01 | 0.2 | |
Return on tangible assets | 0.07 | -0.07 | -0.13 | -0.01 | 0.19 | |
Graham Net | 10.53 | 9.78 | 8.47 | 8.44 | 5.35 | |
Working capital | 995.17M | 899.64M | 760.52M | 749.96M | 1.03B | |
Tangible asset value | 976.01M | 908.86M | 790.26M | 787.85M | 1.05B | |
Net current asset value | 935.55M | 865.35M | 752.73M | 748.78M | 1.01B | |
Invested capital | 0.03 | 0.02 | 0.02 | 0.01 | 0 | |
Average receivables | 14.34M | 17.14M | 7.32M | 8.5M | 3.98M | |
Average payables | 11.51M | 11.26M | 13.06M | 16.65M | 47.39M | |
Average inventory | 1.47M | 1.47M | 0.5 | 3.75M | 3.75M | |
Days sales outstanding | 37.15 | 32.79 | 142.62 | 12.72 | 0 | |
Days payables outstanding | 41.42 | 103.97 | 78.33 | 105.54 | 99.2 | |
Days of inventory on hand | 14.81 | 0 | 0 | 36.82 | 0 | |
Receivables turnover | 9.82 | 11.13 | 2.56 | 28.69 | 0 | |
Payables turnover | 8.81 | 3.51 | 4.66 | 3.46 | 3.68 | |
Inventory turnover | 24.64 | 0 | 55.07M | 9.91 | 0 | |
ROE | 0.09 | -0.08 | -0.15 | -0.01 | 0.22 | |
Capex per share | -0.04 | -0.14 | -0.05 | -0.14 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.02 | 4.46 | 0.03 | 2.37 | 0.12 | |
Net income per share | -0.66 | 3.33 | -1.16 | 1.42 | -0.99 | |
Operating cash flow per share | -0.66 | 3.39 | -0.72 | -0.6 | 1.32 | |
Free cash flow per share | -0.7 | 3.39 | -0.73 | -0.6 | 1.32 | |
Cash per share | 9.14 | 12.55 | 11.81 | 7.91 | 6.93 | |
Book value per share | 8.92 | 12.31 | 11.27 | 12.79 | 11.85 | |
Tangible book value per share | 8.92 | 12.31 | 11.27 | 12.79 | 11.85 | |
Share holders equity per share | 8.92 | 12.31 | 11.27 | 12.79 | 11.85 | |
Interest debt per share | 0.11 | 0.11 | -0.03 | 0.04 | 0.13 | |
Market cap | 23.96B | 22.16B | 24.87B | 24.98B | 23.65B | |
Enterprise value | 23.17B | 21.06B | 23.84B | 24.28B | 23.04B | |
P/E ratio | -103.5 | 18.85 | -60.78 | 49.98 | -67.77 | |
Price to sales ratio | 11.47K | 56.33 | 9.19K | 119.61 | 2.15K | |
POCF ratio | -411.67 | 74.12 | -389.73 | -471.91 | 202.52 | |
PFCF ratio | -387.4 | 74.12 | -384.31 | -471.91 | 202.52 | |
P/B Ratio | 30.48 | 20.42 | 25.02 | 22.13 | 22.6 | |
PTB ratio | 30.48 | 20.42 | 25.02 | 22.13 | 22.6 | |
EV to sales | 11.08K | 53.54 | 8.81K | 116.28 | 2.09K | |
Enterprise value over EBITDA | -428.4 | 67.85 | -247.52 | 166.87 | -308.01 | |
EV to operating cash flow | -398.01 | 70.45 | -373.49 | -458.79 | 197.33 | |
EV to free cash flow | -374.55 | 70.45 | -368.3 | -458.79 | 197.33 | |
Earnings yield | 0 | 0.01 | 0 | 0.01 | 0 | |
Free cash flow yield | 0 | 0.01 | 0 | 0 | 0 | |
Debt to equity | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Net debt to EBITDA | 14.71 | -3.54 | 10.76 | -4.77 | 8.11 | |
Current ratio | 11.58 | 16.28 | 11.59 | 10.81 | 9.22 | |
Interest coverage | 1.01K | 143.07 | 11.89 | 388.76 | -9.36 | |
Income quality | 0.96 | 0.99 | 0.63 | -0.4 | -1.34 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 6.77 | 0.08 | 5.74 | 0.07 | 2.58 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.06 | 0 | 0.01 | 0 | 0 | |
Capex to revenue | -1.74 | 0 | -0.33 | 0 | 0 | |
Capex to depreciation | -0.95 | 0 | -0.2 | 0 | 0 | |
Stock based compensation to revenue | 1.32 | 0 | 0 | 0 | 0 | |
Graham number | 11.49 | 30.39 | 17.15 | 20.18 | 16.23 | |
ROIC | -0.08 | 0.26 | -0.11 | 0.1 | -0.09 | |
Return on tangible assets | -0.07 | 0.25 | -0.09 | 0.1 | -0.07 | |
Graham Net | 8.43 | 11.76 | 10.77 | 6.62 | 5.35 | |
Working capital | 749.96M | 1.05B | 964.21M | 1.1B | 1.03B | |
Tangible asset value | 787.85M | 1.09B | 995.66M | 1.13B | 1.05B | |
Net current asset value | 748.78M | 1.05B | 962.68M | 1.1B | 1.01B | |
Invested capital | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Average receivables | 3.98M | 3.98M | 0 | 0 | 0 | |
Average payables | 16.32M | 23.93M | 34.96M | 51.52M | 66.39M | |
Average inventory | 3.75M | 3.75M | 0 | 0 | 0 | |
Days sales outstanding | 342.65 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 136.78 | 78.74 | 252.39 | 346.21 | 106.08 | |
Days of inventory on hand | 47.71 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.26 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.66 | 1.14 | 0.36 | 0.26 | 0.85 | |
Inventory turnover | 1.89 | 0 | 0 | 0 | 0 | |
ROE | -0.07 | 0.27 | -0.1 | 0.11 | -0.08 | |
Capex per share | -0.04 | 0 | -0.01 | 0 | 0 |
BIOA-B.ST Frequently Asked Questions
What is BioArctic AB (publ) stock symbol ?
BioArctic AB (publ) is a SE stock and trading under the symbol BIOA-B.ST
What is BioArctic AB (publ) stock quote today ?
BioArctic AB (publ) stock price is $197 today.
Is BioArctic AB (publ) stock public?
Yes, BioArctic AB (publ) is a publicly traded company.